Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study
- PMID: 19759838
- PMCID: PMC2744083
- DOI: 10.1016/j.brs.2008.04.002
Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study
Abstract
Background: In a recent preliminary trial in 20 patients after gastric bypass surgery, 20 minutes of repetitive transcranial magnetic stimulation (TMS) over the left prefrontal cortex was associated with a 40% reduction in postoperative patient-controlled morphine use. As is the case with all novel scientific findings, and especially those that might have an impact on clinical practice, replicability is paramount. This study sought to test this finding for replication and to more accurately estimate the effect size of this brief intervention on postoperative morphine use and postoperative pain and mood ratings.
Methods: Twenty participants who underwent gastric bypass surgery completed this replication and extension study. Beck Depression Inventory and Center for Epidemiological Studies Depression scale scores were collected before surgery and at the time of discharge from the hospital. Immediately after surgery, participants were randomly assigned to receive 20 minutes of real or sham repetitive TMS (rTMS) (10 Hz, 10 seconds-ON, 20 seconds-OFF for a total of 4000 pulses). Patient-controlled morphine pump usage was tracked throughout each participant's postoperative hospital stay. In addition, pain and mood ratings were collected via visual analogue scales twice per day.
Results: Findings from the original postoperative TMS trial were replicated, as cumulative morphine usage curves were significantly steeper among patients receiving sham TMS, and participants receiving real TMS had used 35% less morphine at the time of discharge than participants receiving sham TMS. At the time of discharge, subjects who had received real TMS had used 42.50 mg of morphine, whereas subjects receiving sham TMS had used an average of 64.88 mg. When the data from the original preliminary trial were combined with the data from this replication trial, a significant difference in cumulative morphine usage was observed between subjects receiving real and sham TMS. Overall, participants who received real TMS used 36% less morphine and had significantly lower ratings of postoperative pain-on-average, and pain-at-its-worst than participants receiving sham. In addition, participants who received real TMS rated their mood-at-its-worst as significantly better than participants receiving sham. The effect of a single 20-minute session of TMS on postoperative pain and morphine use appears to be large (Cohen's d = 0.70) and clinically meaningful. Lastly, cross-lag correlational analyses indicate that improvements in mood follow improvements in pain by approximately 12 hours, supporting the notion that postoperative analgesic TMS effects are not driven by antidepressant effects.
Conclusions: Although more research is needed to verify these observed effects independently, findings from the original postoperative TMS trial were replicated. TMS may have the potential to significantly improve current standards of postoperative care among gastric bypass patients, and further studies may be warranted on other surgical populations. Future investigations should use methodology that permits more definitive conclusions about causal effects of TMS on postoperative pain (for example, double-blinding, sham stimulation that is matched with real TMS with respect to scalp discomfort).
Keywords: TMS; pain; postoperative; transcranial magnetic stimulation.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2744083/bin/nihms96866f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2744083/bin/nihms96866f2.gif)
Similar articles
-
Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use.Anesthesiology. 2006 Sep;105(3):557-62. doi: 10.1097/00000542-200609000-00020. Anesthesiology. 2006. PMID: 16931989 Clinical Trial.
-
The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.Brain Stimul. 2013 Nov;6(6):925-8. doi: 10.1016/j.brs.2013.04.009. Epub 2013 May 21. Brain Stimul. 2013. PMID: 23769413 Free PMC article. Clinical Trial.
-
Fast left prefrontal rTMS reduces post-gastric bypass surgery pain: findings from a large-scale, double-blind, sham-controlled clinical trial.Brain Stimul. 2014 Jan-Feb;7(1):42-8. doi: 10.1016/j.brs.2013.07.007. Brain Stimul. 2014. PMID: 24527503 Clinical Trial.
-
Blinding success of rTMS applied to the dorsolateral prefrontal cortex in randomised sham-controlled trials: a systematic review.World J Biol Psychiatry. 2011 Jun;12(4):240-8. doi: 10.3109/15622975.2010.541281. Epub 2011 Mar 23. World J Biol Psychiatry. 2011. PMID: 21426265 Review.
-
The expanding evidence base for rTMS treatment of depression.Curr Opin Psychiatry. 2013 Jan;26(1):13-8. doi: 10.1097/YCO.0b013e32835ab46d. Curr Opin Psychiatry. 2013. PMID: 23154644 Free PMC article. Review.
Cited by
-
A novel theta-controlled vibrotactile brain-computer interface to treat chronic pain: a pilot study.Sci Rep. 2024 Feb 10;14(1):3433. doi: 10.1038/s41598-024-53261-3. Sci Rep. 2024. PMID: 38341457 Free PMC article.
-
Brain stimulation targets for chronic pain: Insights from meta-analysis, functional connectivity and literature review.Neurotherapeutics. 2024 Jan;21(1):e00297. doi: 10.1016/j.neurot.2023.10.007. Epub 2023 Dec 19. Neurotherapeutics. 2024. PMID: 38237403 Free PMC article. Review.
-
Multichannel transcranial direct current stimulation over the left dorsolateral prefrontal cortex may modulate the induction of secondary hyperalgesia, a double-blinded cross-over study in healthy volunteers.PLoS One. 2022 Jun 16;17(6):e0270047. doi: 10.1371/journal.pone.0270047. eCollection 2022. PLoS One. 2022. PMID: 35709234 Free PMC article.
-
Enhancement of morphine-induced antinociception after electroconvulsive shock in mice.Mol Pain. 2021 Jan-Dec;17:1744806921992628. doi: 10.1177/1744806921992628. Mol Pain. 2021. PMID: 33599155 Free PMC article.
-
New Developments in Non-invasive Brain Stimulation in Chronic Pain.Curr Phys Med Rehabil Rep. 2020 Sep;8(3):280-292. doi: 10.1007/s40141-020-00260-w. Epub 2020 May 11. Curr Phys Med Rehabil Rep. 2020. PMID: 33473332 Free PMC article.
References
-
- Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003;126:1079–1091. - PubMed
-
- Hadjipavlou G, Dunckley P, Behrens TE, Tracey I. Determining anatomical connectivities between cortical and brainstem pain processing regions in humans: a diffusion tensor imaging study in healthy controls. Pain. 2006;123(1–2):169–178. - PubMed
-
- Reid P, Pridmore S. Improvement in chronic pain with transcranial magnetic stimulation. Aust N Z J Psychiatry. 2001;35(2):252. - PubMed
-
- Graff-Guerrero A, Gonzalez-Olvera J, Fresan A, Gomez-Martin D, Mendez-Nunez JC, Pellicer F. Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain. Brain Res Cogn Brain Res. 2005;25(1):153–160. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous